Join to View Full Profile
30 Prospect AvenueDepartment of Internal MedicineHackensack, NJ 07601
Phone+1 551-996-3500
Fax+1 551-996-3298
Dr. Go is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2013
Maimonides Medical CenterResidency, Internal Medicine, 2007 - 2009
Atlantic HealthInternship, Internal Medicine, 2006 - 2007
Angeles University FoundationClass of 2004
Certifications & Licensure
NJ State Medical License 2015 - 2027
NY State Medical License 2010 - 2027
MA State Medical License 2009 - 2026
NC State Medical License 2009 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Editorial: Non-pharmacologic approaches to inflammation in the critically ill.Ronaldo C Go, Themba Nyirenda
Frontiers in Medicine. 2026-01-01 - 27 citationsTocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA).Ivan O Rosas, Norbert Bräu, Michael Waters, Ronaldo C Go, Atul Malhotra
Eclinicalmedicine. 2022-05-01 - 12 citationsAssociation of Surge Conditions with Mortality Among Critically Ill Patients with COVID-19.Adam B Keene, Andrew J Admon, Samantha K Brenner, Shruti Gupta, Deepa Lazarous
Journal of Intensive Care Medicine. 2022-04-01
Journal Articles
- Tocilizumab in Hospitalized Patients with Severe Covid-19 PneumoniaIvan O Rosas, Ronaldo C Go, Ivor S Douglas, Larry Tsai, Atul Malhotra, The New England Journal of Medicine
- Tocilizumab Among Patients with COVID-19 in the Intensive Care Unit: A Multicentre Observational StudyNoa Biran, Andrew Ip, Ronaldo Collo Go, The Lancet Rheumatology
Authored Content
- Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational studyAugust 2020
- Tocilizumab Among Patients with COVID-19 in the Intensive Care Unit: A Multicentre Observational StudyAugust 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
